***Background.*** *Bacteroides* resistant to β-lactam/β-lactamase inhibitors (βL/βLI) and carbapenems are being increasingly recognized but the prevalence and risk factors are unknown. The purpose of this study is to determine the prevalence of *Bacteroides* resistant to βL/βLIs and carbapenems and identify potential risk factors for the development of resistance to these agents.

***Methods.*** We conducted a single center case-control study of patients with *Bacteroides* bacteremia from January 1, 2010 to August 31, 2013 at a 1,000-bed tertiary medical center. Cases were defined as patients with *Bacteroides* bacteremia resistant to carbapenems and/or βL-βLIs. Cases were matched 1:3 to bacteremic patients with susceptible isolates by year of positive blood culture. We determined the prevalence of *Bacteroides* in the blood resistant or intermediate to βL/βLI and/or carbapenems, risk factors for resistance, and patient outcomes. Cases and controls were compared using Chi square and Wilcoxan rank sum tests. Logistic regression was performed to assess independent predicators of resistance.

***Results.*** 159 unique patients with *Bacteroides* bacteremia were identified. 26 (16%) patients had *Bacteroides* isolates resistant or intermediate to βL/βLI and/or carbapenems. Amoxicillin/clavulanate was the most common agent to which isolates were resistant or intermediate (11.5%), followed by ertapenem (7.0%) and piperacillin-tazobactam (6.8%). 101 patients were included in the case-control analysis. Duration of therapy with a βL/βLI prior to infection was an independent predictor of resistance (OR 1.25; 95% CI 1.08-2.31). More patients with resistant *Bacteroides* died prior to discharge (37.5% vs 4.0%; p = \<0.001) than patients with susceptible organisms.

***Conclusion.*** We found higher resistance rates among *Bacteroides* than what has been reported previously. Duration of exposure to βL/βLI was the only independent risk factor for resistance, supporting judicious use of these agents. There was higher mortality with resistant *Bacteroides*, which is likely confounded by a sicker cohort with a higher percentage in the intensive care unit and longer hospital stay prior to first positive culture.

***Disclosures.*** **All authors:** No reported disclosures.

[^1]: **Session:** 102. Bacteremia: Gram-negative Bacteremia

[^2]: Friday, October 10, 2014: 12:30 PM
